newsfilter
← Latest News
GlobeNewswire·

Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ:RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding